Skip to main navigation Skip to search Skip to main content

Pooled Safety Results Through One Year of Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis.

  • Proton Rahman
  • , Christopher T Ritchlin
  • , Philip S Helliwell
  • , Wolf-Henning Boehncke
  • , Philip J Mease
  • , Alice B Gottlieb
  • , Shelly Kafka
  • , Alexa P Kollmeier
  • , Elizabeth C Hsia
  • , Xie L Xu
  • , May Shawi
  • , Shihong Sheng
  • , Prasheen Agarwal
  • , Bei Zhou
  • , Paraneedharan Ramachandran
  • , Yanli Zhuang
  • , Iain B McInnes

Research output: Contribution to journal › Article

Fingerprint

Dive into the research topics of 'Pooled Safety Results Through One Year of Two Phase-3 Trials of Guselkumab in Patients with Psoriatic Arthritis.'. Together they form a unique fingerprint.
Sort by

Pharmacology, Toxicology and Pharmaceutical Science

Immunology and Microbiology